14-05-2024
|
|
|
IRM ENERGY LIMITED has informed the Exchange about Board Meeting to be held on 21-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Dividend on preference shares. |
|
|
|
14-05-2024
|
|
|
Monitoring Agency Report for the quarter ended March 31, 2024 |
|
|
|
03-05-2024
|
|
|
IRM ENERGY LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
03-05-2024
|
|
|
IRM Energy Limited has informed the Exchange about change in Management |
|
|
|
02-05-2024
|
|
|
Cadila Pharmaceuticals Ltd, IRM trustï¿‚ï¾ and Rajiv Indrvadan Modi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaï¿‚ï¾ (Substantial Acquisition of Shares and Takeovers) Regulations, |
|
|
|
20-04-2024
|
|
|
Significant increase in volume has been observed in IRM Energy Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. IRM Energy Limited has submitted their response. |
|
|
|
19-04-2024
|
|
|
Significant increase in volume has been observed in IRM Energy Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, |
|
|
|
10-04-2024
|
|
|
IRM Energy Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
28-03-2024
|
|
|
IRM Energy Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
28-03-2024
|
|
|
IRM ENERGY LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|